Defining Optimal Immunotherapies for Type 1 Diabetes

Defining Optimal Immunotherapies for Type 1 Diabetes
Defining Optimal Immunotherapies for Type 1 Diabetes
Subtitle: Novartis Foundation Symposium

by: Novartis Foundation

Paperback: 224 pages

Publisher: John Wiley & Sons, Ltd.( October 24, 2008 )

ISBN-10: 0470723254